These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22235796)

  • 1. Serum neopterin, sialic acid and nitric oxide levels in dogs with malignant mammary tumours.
    Tascene N; Kısmalı G; Vural S; Karagul H; Sel T
    Vet Comp Oncol; 2012 Jun; 10(2):155-9. PubMed ID: 22235796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum neopterin levels in female dogs with malignant mammary tumours.
    Szczubiał M; Dąbrowski R; Łopuszyński W
    Vet Comp Oncol; 2014 Jun; 12(2):143-8. PubMed ID: 22882538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum neopterin and C-reactive protein concentrations in female dogs with mammary gland tumours.
    Szczubiał M; Dabrowski R; Łopuszyński W; Bochniarz M; Krawczyk M
    Pol J Vet Sci; 2018 Dec; 21(4):691-696. PubMed ID: 30605283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid and sialyltransferase activity in serum and tissues of dogs with mammary tumors.
    Paltrinieri S; Rossi G; Meregalli A; Stefanello D; Pecile A; Moretti P; Rondena M
    Vet Pathol; 2012 Jul; 49(4):669-81. PubMed ID: 21427240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of steroid hormones and prolactin in canine mammary cancer.
    Queiroga FL; Pérez-Alenza MD; Silvan G; Peña L; Lopes C; Illera JC
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):181-7. PubMed ID: 15862964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total serum sialic acid is a general disease marker rather than a specific tumour marker in dogs.
    Thougaard AV; Hellmén E; Jensen AL
    Zentralbl Veterinarmed A; 1998 Oct; 45(8):471-9. PubMed ID: 9838859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C; Lin D; Wang J; Wang L
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias.
    Gelaleti GB; Jardim BV; Leonel C; Moschetta MG; Zuccari DA
    Vet Immunol Immunopathol; 2012 Apr; 146(2):106-12. PubMed ID: 22405680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and Tissue Steroid Hormone Levels in Canine Mammary Tumours: Clinical and Prognostic Implications.
    Queiroga FL; Pérez-Alenza D; González-Gil A; Silván G; Peña L; Illera JC
    Reprod Domest Anim; 2015 Oct; 50(5):858-65. PubMed ID: 26332137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between alpha 1-acid glycoprotein and total sialic acid in serum from dogs with tumours.
    Thougaard AV; Hellmén E; Pedersen HD; Jensen AL
    Zentralbl Veterinarmed A; 1999 May; 46(4):231-7. PubMed ID: 10399482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene.
    Hsu WL; Huang HM; Liao JW; Wong ML; Chang SC
    Vet J; 2009 Apr; 180(1):116-23. PubMed ID: 18061495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin binding in benign and malignant mammary tissue of female dogs.
    Rutteman GR; Willekes-Koolschijn N; Bevers MM; Van der Gugten AA; Misdorp W
    Anticancer Res; 1986; 6(4):829-35. PubMed ID: 3019223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer.
    Campos LC; Silva JO; Santos FS; Araújo MR; Lavalle GE; Ferreira E; Cassali GD
    J Vet Diagn Invest; 2015 Jul; 27(4):531-5. PubMed ID: 26179096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours.
    Queiroga FL; Pérez-Alenza MD; González Gil A; Silvan G; Peña L; Illera JC
    Vet Rec; 2014 Oct; 175(16):403. PubMed ID: 25096592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
    Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
    Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
    Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
    Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal background of canine and feline mammary tumours.
    Rutteman GR; Misdorp W
    J Reprod Fertil Suppl; 1993; 47():483-7. PubMed ID: 8229967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
    Gama A; Gärtner F; Alves A; Schmitt F
    Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.